Racial differences in breast cancer survival in a large urban integrated health system

Cancer

Volumn 121, Issue 20, 2015, Pages 3668-3675

  Roseland, Molly E ^a   Pressler, Mary E ^b   E Lamerato, Lois ^c   Krajenta, Rick ^c   Ruterbusch, Julie J ^a,d   Booza, Jason C ^a   Schwartz, Kendra ^a,d   Simon, Michael S ^a,d  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Medical College of Wisconsin   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

African Americans; breast cancer; health care disparities; race; socioeconomic status; survival

Indexed keywords

HORMONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; COMORBIDITY; DEMOGRAPHY; FEMALE; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIOECONOMICS; UNITED STATES; URBAN AREA; VERY ELDERLY; AFRICAN AMERICAN; BREAST TUMOR; CAUCASIAN; ECONOMICS; EPIDEMIOLOGY; ETHNOLOGY; HEALTH CARE DELIVERY; HEALTH SERVICE; INTEGRATED HEALTH CARE SYSTEM; MORTALITY; PATHOLOGY; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TRENDS;

AFRICAN AMERICANS; BREAST NEOPLASMS; DELIVERY OF HEALTH CARE, INTEGRATED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MICHIGAN; RISK ASSESSMENT; SOCIOECONOMIC FACTORS; SURVIVAL RATE; URBAN HEALTH SERVICES;

EID: 84943580753     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29523     Document Type: Article

References (37)

1. Wheeler SB, Reeder-Hayes KE, Carey LA,. Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist. 2013; 18: 986-993.
2. Barcenas CH, Wells J, Chong D, French J, Looney SW, Samuel TA,. Race as an independent risk factor for breast cancer survival: breast cancer outcomes from the Medical College of Georgia tumor registry. Clin Breast Cancer. 2010; 10: 59-63.
3. Edwards BK, Noone AM, Mariotto AB, et al., Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014; 120: 1290-1314.
4. Ademuyiwa FO, Edge SB, Erwin DO, Orom H, Ambrosone CB, Underwood W III,. Breast cancer racial disparities: unanswered questions. Cancer Res. 2011; 71: 640-644.
5. Morris AM, Rhoads KF, Stain SC, Birkmeyer JD,. Understanding racial disparities in cancer treatment and outcomes. J Am Coll Surg. 2010; 211: 105-113.
6. Akinyemiju TF, Soliman AS, Johnson NJ, et al., Individual and neighborhood socioeconomic status and healthcare resources in relation to black-white breast cancer survival disparities. J Cancer Epidemiol. 2013; 2013: 1-13.
7. Du XL, Fang S, Meyer TE,. Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer. Am J Clin Oncol. 2008; 31: 125-132.
8. Bradley CJ, Given CW, Roberts C,. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002; 94: 490-496.
9. Cross CK, Harris J, Recht A,. Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies. Cancer. 2002; 95: 1988-1999.
10. El Tamer MB, Homel P, Wait RB,. Is race a poor prognostic factor in breast cancer? J Am Coll Surg. 1999; 189: 41-45.
11. Yood MU, Johnson CC, Blount A, et al., Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999; 91: 1487-1491.
12. Perkins P, Cooksley CD, Cox JD,. Breast cancer. Is ethnicity an independent prognostic factor for survival? Cancer. 1996; 78: 1241-1247.
13. Ansell D, Whitman S, Lipton R, Cooper R,. Race, income, and survival from breast cancer at two public hospitals. Cancer. 1993; 72: 2974-2978.
14. Bassett MT, Krieger N,. Social class and black-white differences in breast cancer survival. Am J Public Health. 1986; 76: 1400-1403.
15. Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL,. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009; 101: 984-992.
16. Simon MS, Severson RK,. Racial differences in breast cancer survival: the interaction of socioeconomic status and tumor biology. Am J Obstet Gynecol. 1997; 176: S233-S239.
17. Newman LA, Mason J, Cote D, et al., African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 white American patients with carcinoma of the breast. Cancer. 2002; 94: 2844-2854.
18. O'Malley CD, Le GM, Glaser SL, Shema SJ, West DW,. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study. Cancer. 2003; 97: 1303-1311.
19. Shavers VL, Harlan LC, Stevens JL,. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003; 97: 134-147.
20. Crowe JP Jr, Patrick RJ, Rybicki LA, Grundfest-Broniatowski S, Kim JA, Lee KB,. Race is a fundamental prognostic indicator for 2325 northeastern Ohio women with infiltrating breast cancer. Breast J. 2005; 11: 124-128.
21. Grann V, Troxel AB, Zojwalla N, Hershman D, Glied SA, Jacobson JS,. Regional and racial disparities in breast cancer-specific mortality. Soc Sci Med. 2006; 62: 337-347.
22. Schootman M, Jeffe DB, Gillanders WE, Aft R,. Racial disparities in the development of breast cancer metastases among older women: a multilevel study. Cancer. 2009; 115: 731-740.
23. Komenaka IK, Martinez ME, Pennington RE Jr, et al., Race and ethnicity and breast cancer outcomes in an underinsured population. J Natl Cancer Inst. 2010; 102: 1178-1187.
24. Niu X, Pawlish KS, Roche LM,. Cancer survival disparities by race/ethnicity and socioeconomic status in New Jersey. J Health Care Poor Underserved. 2010; 21: 144-160.
25. Warner ET, Gomez SL,. Impact of neighborhood racial composition and metropolitan residential segregation on disparities in breast cancer stage at diagnosis and survival between black and white women in California. J Community Health. 2010; 35: 398-408.
26. Du XL, Lin CC, Johnson NJ, Altekruse S,. Effects of individual-level socioeconomic factors on racial disparities in cancer treatment and survival: findings from the National Longitudinal Mortality Study, 1979-2003. Cancer. 2011; 117: 3242-3251.
27. Tian N, Wilson JG, Zhan FB,. Spatial association of racial/ethnic disparities between late-stage diagnosis and mortality for female breast cancer: where to intervene? Int J Health Geogr. 2011; 10: 24.
28. Markossian TW, Hines RB, Bayakly R,. Geographic and racial disparities in breast cancer-related outcomes in Georgia. Health Serv Res. 2014; 49: 481-501.
29. Anderson RT, Yang TC, Matthews SA, et al., Breast cancer screening, area deprivation, and later-stage breast cancer in Appalachia: does geography matter? Health Serv Res. 2014; 49: 546-567.
30. Singh GK,. Area deprivation and widening inequalities in US mortality, 1969-1998. Am J Public Health. 2003; 93: 1137-1143.
31. Simon MS, Lamerato L, Krajenta R, et al., Racial differences in the use of adjuvant chemotherapy for breast cancer in a large urban integrated health system. Int J Breast Cancer. 2012; 2012: 1-8.
32. Klassen AC, Curriero FC, Hong JH, et al., The role of area-level influences on prostate cancer grade and stage at diagnosis. Prev Med. 2004; 39: 441-448.
33. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383.
34. Deyo RA, Cherkin DC, Ciol MA,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45: 613-619.
35. O'Brien KM, Cole SR, Tse CK, et al., Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res. 2010; 16: 6100-6110.
36. Burgard SA, Seefeldt KS, Zelner S,. Housing instability and health: findings from the Michigan Recession and Recovery Study. Soc Sci Med. 2012; 75: 2215-2224.
37. Wolff AC, Hammond ME, Schwartz JN, et al., American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007; 25: 118-145.